SMS Pharmaceuticals Ltd — Major Shareholding Notification 2020

Mar 9, 2020

Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana, INDIA. Tel: +91 -40-2525 9999, Fax: +91-40-2525 9889 CIN : L24239TG1987PLC008066 Email: info@smspharma.com, www.smspharma.com

09.03.2020

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

The Manager, Listing Complia n ce Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/l, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Security Code:532815

Symbol: SMSPHARMA

Sub: Disclosure for intimation received from Promoter and Promoter Group for Acquisition / Disposa l of equity shares of the Company.

Dear Sir / Madam,

We received intimation from the following Promoter / Promoter Group pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Regulation 29(2) of the SEB! (Substantial Acquisition of Shares and Takeover) Regulations, 2011 .

Sl.No.	Name	Category	Event	Number of Shares
01	Mr.TWSN Murthv	Promoter	Sale	27,60,000 {3.26%}
0 2	Mrs. T.Anna purna	Promoter	Sale	10,25,000 (1.21%1
03	Mrs.Hima Bindu Potluri	Promoter	Purchase	10,25,000 {1.21%}
04	Mr. Vamsi Krishna Potluri	Promoter Group	Purchase	27,60,000 (3.26%)

The above transactions were within the threshold limit of Regulation 3 of SEBI (SAST) Regulations 2011.

This is for your information and record.

Th?.-.king you.

Yours faithfully

For SMS Pharmaceuticals Limit

~ ~ v S Venkatish Company Secretary & OQP11li<m IOfficer *

07.03.2020

TOt The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/l, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Security Code:532815

Symbol: SMSPHARMA

To,

Mr. V.S.Venkatish Company Secretary & Compliance Officer SMS Pharmaceuticals Limited Regd: Plot.No. 72, H.No. 8-2-334/3&4, Road No.5 Opp.SBI Executive Enclave, Banjara Hills, Hyderabad Telangana - ,'500034 TS

Sub: Disclosure under Regulation 29 (2) of SEBI (SAST) Regulations, 2011 and Regulation 7(2) of SEBI (PIT) Regulations, 2015

Dear Sir/Madam,

With reference to the aforementioned subject, please find enclosed herewith the disclosure as under Regulation 29 (2) of SEBI (SAST) Regulations, 2011 and Regulation 7(2) ofSEBl (PIT) Regulations, 2015

I, T.Annapurna, Promoter Group of SMS Pharmaceuticals Limited (The Company) resident at Plot.No. lO-C, Type C, Road No.8, Film Nagar, Jubilee Hills, Hyderabad, 500033, hereby submit the disclosure with regard to Sale of Equity Shares of the Company, in the open market on 61h March, 2020.

This is for your informali,,", and record

Yours Truly,

-f'-r r[jr(\jYb{:>'N.."'5.lyv:::,j

TAnnapurna Promoter Grou p / Seller

Encl: Disclosure

Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares andTakeovers) Regulations, 2011

	Name of the Target Company (TC)	SMS Pharmaceuticals Limited.Presidente de la contra de la presidencia de la contra de la contra de la contra de la contra de la contra de
	Name(s) of the acquirer / Seller and Persons Acting inConcert (PAC) with the acquirer..	T. Annapurna
	Whether the acquirer belongs to Promoter/Promoter group	Promoter -
Listed	Name(s) of the Stock Exchange(s) where the shares of TC are	BSE & NSE
	Details of the acquisition / disposal as follows	Number	% w.r.t.totalshare/votingcapitalwherever$applicable(*)$	% w.r.t. totaldilutedshare/votingcapital of the TC$(**)$
	Before the acquisition under consideration, holding of:
	a) Shares carrying voting rightsb) Shares in the nature of encumbrance (pledge/lien/non-disposal undertaking/others)c) Voting rights (VR) otherwise than by shares	43,90,340	5.19	5.19
e)	d) Warrants/convertible securities/any other instrumentthat entitles the acquirer to receive shares carryingvoting rights in the T C (specify holding in eachcategory)Total $(a+b+c+d)$	43,90,340	5.19	5.19
	Details of acquisition/sale
a)C)	Shares carrying voting rights acquired/soldb) VRs acquired /sold otherwise than by sharesWarrants/convertible securities/any other instrumentthat entitles the acquirer to receive shares carrying	10,25,000	[1,21]	1.21
d)e)	voting rights in the TC (specify holding in eachcategory) acquired/soldShares encumbered / invoked/released by the acquirerTotal (a+b+c+/-d)	10,25,000	1.21	1.21

TPmonefairmes.

After the acquisition/sale, holding of:
Shares carrying voting rightsa)b)Shares encumbered with the acquirerVRs otherwise than by sharesc)	33,65,340	3.98	3.98
Warrants/convertible securities/any other instrumentd)that entitles the acquirer to receive shares carryingvoting rights in the TC (specify holding in eachcategory) after acquisitionTotal $(a+b+c+d)$e)	33,65,340	3.98	3.98
Mode of aequisition / sale (e.g. open market / off-market /public issue / rights issue / preferential allotment / inter-setransfer etc).	Open Market
Date of acquisition / sale of shares / VR or date of receipt ofintimation of allotment of shares, whichever is applicable	06-03-2020
Equity share capital / total voting capital of the TC before thesaid acquisition / sale	8,46,52,030 Equity shares of Re.one each
Equity share capital/ total voting capital of the TC after thesaid acquisition / sale	8,46,52,030 Equity shares of Re.one each
Total diluted share/voting capital of the TC after the saidacquisition	8,46,52,030 Equity shares of Re.one each

T.Annapurna

7 T. Amnopioano.

Signature of the acquirer / seller / Authorised-Signatory

Place: Hyderabad

Date: 07-03-2020

******

$\hat{\mathbf{r}}_t$

FORM C

Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (2) read with Regulation 6(2)]

Name of the company: SMS Pharmaceuticals Limited

$\sim$

ISIN of the company: INE812G01025Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).

$\mathcal{L}_{\mathcal{A}}$

Name,PANNo.,CIN/DIN,& addressofPromoter/Employee /	Categoryof Person(Promoters$/$ KMP $/$Directors/immediaterelatives/othersetc.)	Securities heldprior toacquisition/disposal/Relete			Securitiesacquired/Disposed/release				Securities held postacquisition/disposal/release:		Date ofallotmentadvice/acquisition ofshares/sale of sharesspecify-		Mode ofAcquisitien/Disposai(marketpurchase/public
Directorwithcontactnos.		Typeоfsecurity(For$eg. -$SharesWarranis,ConvertibleDebentures etc.)	No.and %ofshareholding	Type ofsecurity(For eg. $-$Shares,Warrants,ConvertibleDebenturesetc.)	No.	Value	TransactionType(Buy/Sale/Pledge /Revoke/Invoke)release	Type ofsecurity(For eg.Shares,WarrantSConvertibleDebentures etc.)	No. and %ofshareholding	From	To		rights/preferentialoffer / offmarket/Inter-setransferetc
	$\overline{2}$	$\mathfrak{Z}$	$\overline{4}$	5	6	7	8	9	10	11	12	13	14
T.AnnapurnaPAN:ABIPT9230CH.No: Plot.No.10-c, Type - C,Road No.8, FilmNagar, JubileeHills, Hyderabad500033 TS	Promoter	Èquity.shares	43,90,3405.19%	EquityShares	10,25,0001.21%	3,73,83,529	Sale	EquityShares	33,65,3403.98%	06-03-2020	$06-03-$2020	$07-03-$2020	OpenMarket

Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2)

ITrading in derivatives (Specify type of contract, Futures or Options etc)
Type of	I	Buy		Sell
Contract!	ContractSpecificationsI	<' Notional Value	Number of units(contracts * lotsize)	Notional Value	INumber of units(contracts * lot: size)
J 15	116	117	1 1.8	119	120	21'1
			,NA

-F T ' H-S)"'0"--'''''''-P~~.f'V-;>J ,

::-«

Signature: T.Annapurna

Date: 07-03-2020 Place: Hyderabad

07.03.2020

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumb'li- 400 DOl

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/l, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Security Code:532815

Symbol: SMSPHARMA

To,

M". V.S.Venkatish Company Secretary & Compliance Officer SMS Pharmaceuticals Limited Regd: Plot.No. 72, H.No. 8-2-334/3&4, Road No.5 Opp.SBl Executive Enclave, Banjara Hills, Hyderabad 1'elangana - 500034 1'S

Sub: Disclosure under Regulation 29 (2) of SEB! (SAST) Regulations, 2011 and Regulation 7(2} of SEBI (PIT) Regulations, 2015

Dear Sir/Madam,

With reference to the aforementioned subject, please find enclosed herewith the disclosure as under Regulation 29 (2) of SEBI (SAS1') Regulations,2011 and Regulation 7(2) of SEBI (PIT) Regulations, 2015

I, TVVSN Murthy, Promoter of SMS Pharmaceuticals I,imiled (The Company) resident at Plot.No. 10-C, Type C, Road No.8, Film Nagar, Jubilee Bills, Byderabad, 500033, hereby submit the disclosure with regard to Sale. of Equity Shares of the Company, in the open market on 61h March, 2020.

This is for your information and record

::ursr1Y,

TVVSN~~ Promoter jSellcr

Encl: Disclosure

Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares andTakeovers) Regulations, 2011

$\sim$ $\sim$

	Name of the Target Company (TC)	SMS Pharmaceuticals LimitedTVVSN Murthy
	Name(s) of the acquirer / Seller and Persons Acting inConcert (PAC) with the acquirer
	Whether the acquirer belongs to Promoter/Promoter group	Promoter
Listed	Name(s) of the Stock Exchange(s) where the shares of TC are	BSE & NSE
	Details of the acquisition / disposal as follows	Number	% w.r.t.totalshare/votingcapitalwhereverapplicable $(*)$	% w.r.t. totaldilutedshare/votingcapital of the TC$(**)$
	Before the acquisition under consideration, holding of :
	a) Shares carrying voting rightsb) Shares in the nature of encumbrance (pledge/lien/non-disposal undertaking/others)c) Voting rights (VR) otherwise than by sharesd) Warrants/convertible securities/any other instrumentthat entitles the acquirer to receive shares carrying	82,27,000	9.72	9.72
	voting rights in the T C (specify holding in eachcategory)e) Total $(a+ b+c+d)$	82,27,000	9.72	9.72
	Details of nequisition/sale
c)	a) Shares carrying voting rights acquired/soldb) VRs acquired /sold otherwise than by sharesWarrants/convertible securities/any other instrumentthat entitles the acquirer to receive shares carryingvoting rights in the TC (specify holding in each	27,60,000	3.26	3.26
	category) acquired/soldd) Shares encumbered / invoked/released by the acquirere) Total $(a+b+c+f-d)$	27,60,000	3.26	3.26

and an in conservation of the communication of a communication and an annual communication and conservation of

After the nequisition/sale, holding of:
Shares carrying voting rightsa)Shares encumbered with the acquirer$\mathbf{b}$VRs otherwise than by shares$\mathbf{c}$	54,67,000	6.46	6.46
Warrants/convertible securities/any other instrument$\mathbf{d}$that entitles the acquirer to receive shares carryingvoting rights in the TC (specify holding in eachcategory) after acquisitionTotal (a+b+c+d)e)	54,67,000	6.46	6.46
Mode of acquisition / sale (e.g. open market / off-market /public issue / rights issue / preferential allotment / inter-setransfer etc).	Open Market
Date of acquisition-/ sale of shares / VR-or-date of receipt ofintimation of allotment of shares, whichever is applicable	06-03-2020
Equity share capital / total voting capital of the TC before thesaid acquisition / sale	8,46,52,030 Equity Shares of Re. one each
Equity share capital/ total voting capital of the TC after thesaid acquisition / sale			8,46,52,030 Equity Shares of Re. one each
Total diluted share/voting capital of the TC after the saidacquisition	8,46,52,030 Equity Shares of Re. one each

TVVSN Mythy

$\ddot{\phantom{a}}$

$\overline{\mathbf{y}}$ ÷.

Signature of the acquirer / seller / Authorised-Signatory

Place: Hyderabad

Date:07-03-2020

******

$\sim 10^{11}$ and $\sim 10^{11}$

FORM C

Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015[Regulation 7 (2) read with Regulation 6(2)]

$\sim$ $\sim$

Name of the company: SMS Pharmaceuticals LimitedISIN of the company: INE812G01025Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Reg

$\langle \cdot \rangle$

Name,PANNoCIN/DIN,& addressofPromoter/Employee /Director	Categoryof Person(Promoters)/KMP/Directors/immediaterelatives/	Securities heldprior toacquisition/disposal/ReleaseNo.Type		Securitiesacquired/Disposed/releaseValueTransactNo.Type of			Securities held postacquisition/disposal/releaseType ofNo. and %		Date ofallotmentadvice/acquisition ofshares/sale of sharesspecifyToFrom		Date$\sigma f$intima -tion tocompa$\Omega V$	Mode ofAcquisitien/Disposal(marketpurchase/publicrights/
	withcontactnos:	othersetc.)	of.security(Foreg.SharesWarrants.ConvertibleDebenture$s$ etc.).	and %ofshareholding	security(For eg. -Shares.Warrants,ConvertibleDebenturesetc.)			ionType(Buy/Sale/Pledge /Revoke/Invoke)release	security(For eg.Shares.WarrantsConvertibleDebentures etc.)	ofshareholding				preferentialoffer / offmarket/Inter-setransferetc
		$\overline{2}$	3	4	5	6	7	8	9	10 7	11	12	13	14
	TVVSN MurthyPAN:ABKPT0255FH.No: Plot.No:$10-C$ , type $-C$ .Road No. 8, filmNagar, JubileeHills, HyderabadTS.	Promoter	EquitŸ.shares	82,27,0009.72%	EquityShares	27,60,0003.26%	Rs.10,00,50,000	Sale.	EquityShares	54,67,0006.46%	06-03-2020	$06 - 03 -$2020	$07 - 03 -$2020	OpenMarket

J.

Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2)

	Trading in derivatives (Specify type of contract, Futures or Options etc)					1 Exchange on which thetrade was executed
Type of	Contract	Buy		Sell
Contract	Specifications	Notional Value	Number of units(contracts * lotsize)	Notional Value	Number of units(contracts * lot)size)
	16		18	19	20
			Na

$\mathbb{R}^2$

Signature: TVVSN Murthy

$\overline{\phantom{a}}$

$\sim$

Date: 07.03.2020Place: Hyderabad

$\sim$

07.03.2020

To, The Manager, Corporate FiHngs Departnlcnt, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/l, G Block, Bandra-Kurla Complex, Bandra (E), Mumba! - 400 051.

Security Code:532815

Symbol: SMSPHARMA

To,

Mr. V.S.Venkatish Company Secretary & Compliance Offlcer SMS Pharmaceuticals Limited Regd: PloLNo. 72, H.No. 8-2-334/3&4, Road No.5 Opp.SBI Executive Enclave, Banjara Hills, Hyderabad Tclangana - 500034 TS

Sub: Disclosure uuder Regulation 29 (2) of SEBI (SAST) Regulations, 2011 and Regulation 7(2) of SEBI (PIT) Regulations, 2015

Dear Sir/Madam,

With reference to the aforementioned subject, please find enclosed herewith the disclosure as under Regulation 29 (2) of SEBI (SAST) Regulations, 2011 and Regulation 7(2) of SEBI (PIT) Regulations, 2015

I, Vamsi Krishlla Potluri, Promoter Group of SMS Pharmaceuticals Limited (The Company) residing at PloLNo. 265 Q, Road No. 10, Jubilee Hills, Hyderabad 500033 TS, hereby submit the disclosure with regard to purchase of Equity Shares of the Company, in the open market on 6th March, 2020.

This is for your information and record

~J:llY'

Vmhna Potluri Promoter Group/ Purchaser

Encl: Disclosure

Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares andTakeovers) Regulations, 2011

$\sim$

$\label{eq:2.1} \frac{1}{2} \int_{-\infty}^{\infty} \frac{1}{2} , dx , dx = 0$

Name of the Target Company (TC)		SMS Pharmaceuticals Limited
Name(s) of the acquirer and Persons Acting in Concert (PAC)with the acquirer		Vamsi Krishna Potluri
Whether the acquirer belongs to Promoter/Promoter group	Promoter Group
Name(s) of the Stock Exchange(s) where the shares of TC areListed	BSE & NSE
Details of the acquisition / disposal as follows	Number	% w.r.t.totalshare/votingcapitalwherever$applicable(*)$	% w.r.t. totaldilutedshare/votingcapital of the TC$(**)$
Before the acquisition under consideration, holding of :
Shares carrying voting rightsa)Shares in the nature of encumbrance (pledge/lien/b)non-disposal undertaking/others)Voting rights (VR) otherwise than by sharesC)Warrants/convertible securities/any other instrument$\mathbf{d}$that entitles the acquirer to receive shares carryingvoting rights in the T C (specify holding in eachcategory)Total (a+b+c+d)e)	20,50,590 2.4220,50,590	2.42	2.422.42
Details of acquisition/salea) Shares carrying voting rights acquired/soldVRs acquired /sold otherwise than by sharesb)Warrants/convertible securities/any other instrumentc)that entitles the acquirer to receive shares carryingvoting rights in the TC (specify holding in eachcategory) acquired/soldShares encumbered / invoked/released by the acquirerd).Total (a+b+c+/-d)e)	27,60,00027,60,000	3.263.26	3.263.26

$\mathcal{G}^{\mathcal{G}}$

After the acquisition/sale, holding of:
Shares carrying voting rightsa)Shares encumbered with the acquirer$\mathbf{b}$VRs otherwise than by sharesC)Warrants/convertible securities/any other instrumentd)that entitles the acquirer to receive shares carrying	48,10,590	5.68	5.68
voting rights in the TC (specify holding in eachcategory) after acquisitionTotal $(a+b+c+d)$e)	48,10,590	5.68	5.68
Mode of acquisition / sale (e.g. open market / off-market /public issue / rights issue / preferential allotment / inter-setransfer etc).	Open Market
Date of acquisition / sale of shares / VR or date of receipt ofintimation of allotment of shares, whichever is applicable		06-03-2020
Equity share capital / total voting capital of the TC before thesaid acquisition / sale		8,46,52,030 Equity Shares of Re. one each
Equity share capital/ total voting capital of the TC after thesaid acquisition / sale			8,46,52,030 Equity Shares of Re. one each
Total diluted share/voting capital of the TC after the saidacquisition	8,46,52,030 Equity Shares of Re. one each

$\mathbb{R}^2$

Vamsi Krishna Potluri Q÷

Signature of the acquirer / seller / Authorised-Signatory

$\hat{\boldsymbol{\alpha}}$

Place: Hyderabad.

÷,

Date: 07-03-2020

******

FORM C

Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015[Regulation 7 (2) read with Regulation 6(2)]

$\sim$

Name of the company: SMS Pharmaceuticals LimitedISIN of the company: INE812G01025Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Re

Name,PAN No.CIN/DIN,& addressοfPromoter/Employee /	Categoryof Person(Promoters)/ KMP /Directors/immediaterelatives/	Securities heldprior toacquisition/disposal/Release			Securitiesacquired/Disposed/release					Securities held postacquisition/dispesal/release		acquisition of	Dateоfintimation tocompa1.y	Mode ofAcquisition/Disposal(marketpurchase/public
	Directorwithcontactnos.	othersetc.)	Typeοfsecurity(For$eg -$SharesWarrants,ConverubleDebentures etc.)	No.and %$\sigma f$shareholding	Type ofsecurity(For eg. -Shares,Warrants,ConvertibleDebenturesetc.	No.	Value	TransactionType(Buy/Sale/Pledge /Revoke/Invoke)release	Type ofsecurity(For eg.Shares,WarrantsConvertibleDebentures etc.)	No. and %$\circ f$shareholding	From	To		rights/preferentia 1offer / offmarket/Inter-setransferetc
		$\mathbf{2}$	3	4	$\overline{5}$	6	7	8	$\mathbf{g}$	$\overline{10}$	11	12	13	14
	Vamsi KrishnaPotluriPAN:AQSPP0412FH.No: Plot No:265Q, Road No.10. Jubilee HillsHyderabad-500034	PromoterGroup	Equit$\mathbf{y}$shares	20,50,5902.42%	EquityShares	27,60,0003.26%	Rs.10,00,50,000	Buy	EquityShares	48,10,5905.68%	06-03-2020	06-03-2020	07-03-2020	OpenMarket

$\mathbf{v}$

التستدارين

Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2)

Trading in derivatives (Specify type of contract, Futures or Options etc)	Exchange on which thetrade was executed
Type of	Contract	Buv		SeH
Contract	Specifications	Notional Value	Number of units(contracts * lot)sizel	Notional Value	Number of units(contracts * lot)size)
	16		18	19	20
			Na

$\sim 10^{11}$ and $\sim 10^{11}$ $\mathcal{L}{\mathcal{S}}$ . The set of $\mathcal{L}{\mathcal{S}}$

Signature: Vamsi Krishna Potluri

$\sim$

$\omega$

$\sim 10^{-1}$

Date: 07.03.2020 Place: Hyderabad

07.03.2020

1"0, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C /1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Security- Code:532815

Sy-mbol: SMSPHARMA

To,

Mr. V.S.Vcnkatish Company Secretmy & Compliance Officer SMS Pharmaceuticals Limited Regd: PloLNo. 72, H.No. 8-2-334/3&4, Road No.5 opp.sm Executive Enclave, Banjara Hills, Hyderabad Telangana - 500034 TS

Sub: Disclosure under Regulation 29 (2) of SEB! (SAST) Regulations, 2011 and RegulaUon7(2) of SEBI (PIT) Regulations, 2015

Dear Sir/Madam,

With reference to the aforementioned subject, please find enclosed herewith the disclosure as under Regulation 29 (2) of SEBI (SAST) Regulations, 2011 and Regulation 7(2) of SEB! (PIT) Regulations, 2015

I, Hima Hindu Porluri, Promoter Group of SMS Pharmaceuticals Limited (The Company) residing at Plot.No. 265 Q, Road No. 10, Jubilee Hills, Hyderabad 500033 TS, hereby SUbmit the disclosure with regard to purchase of Equity Shares of the Company, in the open market on 6th March, 2020.

This is for your information and record

Yours Truly,

p

Hima Bindu Potlud Promoter Group/ Purchaser

Enel: Disclosure

Format for disclosures under BsguJation 29(2) ofSEBJ (Suhstantial Ac«ujsjtjoll QfShilres and Takeoyers) Rel'!llaliolls. 2011

Name or the Target Company (TC)	SMS Pharmaceuticals Limited
Name(s) ofthe acquirer and Persons Acting in Concert (PAC), with the acquirer		Hima Bindu Potluri
Whcthcr the acquirer belongs to Promoter/Promoter group	Promoter,
Name(s) or tile Stock Exchangc(s) where the shares ofTC areListed		ESE & NSE
Details of the acquisition / dispesal as follows	Number	i ! % w,r,t.total! share/voting'Ii capitaI'I wherever, applicable(*)	% w,r,t totaldiluted• share/voting, capital of the TC, (**)
Before the acquisition under considel'lltioll, holding of:		I
Shares carrying voting rightsa)Shares in the nature of encumbrance (pledge/ lien/b)non-disposal undertaking! others)c)Voting rights (VR) otherwise than by sharesWarrants/convertible securities/any other instrument id)that entitles the acquirer to receive shares carryingvoting rights in the T C (specify holding in each'category)	1,23,73,360 i14,62,	!I,III	4,62
e)Total (a+b+c+d)	'1,23,73,360114,62		14.62I
Details of acquisition/SIde		!
a)Shares carrying voting rights acquired/soldVRs acquired /sold otherwise than by sharesb)c)Warrants/conveltible securities/any other instrumentthat entitles the acquirer to receive shares carryingvoting rights in the TC (specify holding in each.	0,25,000		iUI
category) acquired/soldShares encumbered / invoked/relcased by the acquirerd)Total (a+b+c+/-d)0)	;10,2S,OOO	('21	1.21

After the acquisition/sale, holding of:
Shares carrying voting rightsa)Shares encumbered with the acquirerb)	1,33,98,360 15.83	-15.83
VRs otherwise than by shares$\circ$Warrants/convertible securities/any other instrumentd)that entitles the acquirer to receive shares carryingvoting rights in the TC (specify holding in eachcategory) after acquisitionTotal (a+b+c+d)e)	1,33,98,360 15.83		15.83
Mode of acquisition / sale (e.g. open market / off-market /public issue / rights issue / preferential allotment / inter-setransfer etc).	Open Market
Date of acquisition / sale-of-shares / VR or date of receipt ofintimation of allotment of shares, whichever is applicable	06-03-2020
Equity share capital / total voting capital of the TC before thesaid acquisition / sale			8,46,52,030 Equity shares of Re one each
Equity share capital/ total voting capital of the TC after thesaid acquisition / sale	8,46,52,030 Equity shares of Re one each
Total diluted share/voting capital of the TC after the said-acquisition			8,46,52,030 Equity shares of Re one each

Hima Bindu Potluri

Hima Birdu. P.

Signature of the acquirer / seller / Authorised Signatory

Place: Hyderabad

Date: 07-03-2020

******

FORM C

Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015[Regulation 7 (2) read with Regulation 6(2)]

Name of the company: SMS Pharmaceuticals Limited ISIN of the company: INE812G01025ISIN of the company: INE812G01025Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).

$\Delta\phi$

$\mathbb{Z}^{\times}$

$\sim$

$\ddot{\phantom{a}}$

$\sim$

Name,PAN No.CIN/DIN,& addressofPromoter/Employee /	Categoryof Person(Promoters)/KMP/Directors/immediaterelatives/	Securities heldprior toacquisition/disposal/Release		Securitiesacquired/Disposed/-release			Securities held postacquisition/disposal/release		Date ofallounentadvice/acquisition ofshares/sale of sharesspecify-		Date$\sigma$intimation tocompany	Mode ofAcquisition-Disposal(marketpurchase/public
Directorwith.contactnos.	othersetc.)	Typeofsecurity(Foreg. -SharesWarrants,ConvertibleDebentures etc.	No.and %σ£shareholding	Type ofsecurity(For eg.-Shares,Warrants,ConvertibleDebenturesetc.)	No.	Value	TransactionType(Buy)Sale/Pledge /Revoke/Invoke)release	Type ofsecurity(For eg.Shares,Warrant$\mathbf{s}$ConvertibleDebentures etc.)	No. and %ofshareholding	From	To		nghts/preferentialoffer / offmarket/Inter-setransferetc
	$\mathbf{2}$	$\overline{3}$	4	5	$\ddot{6}$	7	8	9	10	$\overline{11}$	$\overline{12}$	$\overline{13}$	$\overline{14}$
Hima BinduPotluriPAN:AAOPP2408HAdd: Plot.No.265 Q, Rd.No. 10,Jubilee HillsHyderabad5000033 TS	Promoter	EquitУshares	1,23,73,36014.62%	EquityShares	10,25,0001.21%	Rs.3,74,86,550	Buy	EquityShares	1,33,98,36015.83%	06-03-2020	$06 - 03 -$2020	$07 - 03 -$2020	ÓpenMarket

Hima Birdu P

states and provide a series of an anti-series of the state

$\mathbb{R}$

Details of trading in derivatives of the company by Promoter, Employee or Director of a'listed company and other such persons as mentioned lil Regulation 6(2)

Trading in derivatives (Specify type of contract, Futures or Options etc)
Type of	! Contract	Buy		Sell		i
ContractI	Specifications	Notional Valuei	Number of units(contracts 1: lotsize)	Notional Value	! Number of units(contracts1: lotsize)	<br>i1
15	16	17	18	19	20	i\ 21
Na---. ~-.- -

a£c:n-P' Si~ature: Rima Bindu PotIuri

Date: 07.032020 Place: Hyderabad